SerbinCreative

(805) 963-0439 | Toll-Free (800) 876-6425

www.serbincreative.com LA / NY / UK

Cidofovir versus Brincidofovir (oral antiviral) 

Prev Next
Previous

Autoimmune Response Mimicry

medical illustration of Drug's mechanism of action graphics at cellular level for pharmaceutical project, explaining how Chimerix’s novel oral antiviral, Brincidofovir, has enhanced intracellular uptake compared to Cidofovir. Brincidofovir has a monoacyl lipid side chain that enables it to rapidly enter by flip-flopping. Keywords: molecular biology, cellular biology, histology, pharmacology, virology, disease management
Next medical illustration of One in a series discussing colonization cycle of C Difficile bacterial Infection. Use by pharma company for prelaunch training and education.

C Difficile Infection Cycle

Drug's mechanism of action graphics at cellular level for pharmaceutical project, explaining how Chimerix’s novel oral antiviral, Brincidofovir, has enhanced intracellular uptake compared to Cidofovir. Brincidofovir has a monoacyl lipid side chain that enables it to rapidly enter by flip-flopping. Keywords: molecular biology, cellular biology, histology, pharmacology, virology, disease management

Keywords: Advertising / Marketing, Allergy / Immunology, Biology, Biotechnology, Cell biology / Histology, Disease Management, Endocrinology / Metabolic, Molecular Biology, Pharmacology, Virology

© Mica Duran